CHEK2 and neoplasm: Growth curves indicate that the tumor-derived cell lines expressing different shRNAs against ATM and CHEK2 had their proliferation potential dramatically reduced, but that silencing of these genes did not affect the proliferation of PHK (Figure 2B).